Share through
St. Jude Research Logo
About Us
Care & Treatment
Research
Training
Get Involved
Ways to Give
St. Jude Research
WHY ST. JUDE
Back
WHY ST. JUDE
Data and Visualization Tools
Shared Resources
Why St.Jude
Translation Innovation
Scientific Milestones
DEPARTMENTS & LABS
Back
DEPARTMENTS & LABS
Departments
View all departments
Labs
View all labs
Clinical Research
View all clinical researchers
CENTERS & INITIATIVES
Back
CENTERS & INITIATIVES
Comprehensive Cancer Center
Pediatric Translational Neuroscience Initiative
Blue Sky
St. Jude Research Collaboratives
Centers & Initiatives
Global Impact on Infectious Disease
Center of Excellence for Data-Driven Discovery
CAREERS
Search
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Home
Why St. Jude
Shared resources & core facilities
Technology Licensing
Drug discovery & development tools
Drug discovery & development tools
Caspase 1 inhibition (SJ-13-0039)
Chimeric gene and protein generated Optogranules: Light induced stress granules (SJ-18-0010)
Diagnosing and treating learning or mental disorders with SERCA2 protein and miRNAs (SJ-10-0003, SJ-12-0020)
Discovery of a novel inhibitor of constitutive androstane receptor (CAR) that does not activate pregnane X receptor (PXR) (SJ-14-0039)
FRET assay for G3BP1 and G3BP2 inhibitors (SJ-19-0043)
Inhibiting Mir-451 to treat Beta-Thalassemia (SJ-20-0030)
LANDO pathway disruption for Alzheimer's disease (SJ-19-0020)
Modulating non-canonical autophagy (LAP) in myeloid cells to suppress tumors (SJ-17-0019)
Preventing and treating hearing loss using CDK2 inhibitors (SJ-14-0028)
Rapid cloning of T cell receptors (SJ-16-0001)
Regulating p53 translation and function (SJ-05-0002)
Respiratory cell isolation and propagation for pathogen study (SJ-18-0028)
SCCRO peptide inhibitor (SJ-11-0014)
Small molecule BODIPY FL VH032 probe for E3 ligase (SJ-21-0014)
Use of specific retinoid receptor agonists and antagonists as cancer therapies (SJ-14-0011)
miRNAs for treating cerebral ventricle enlargement in schizophrenia patients (SJ-19-0039)
For more information
Contact the
Office of Technology Licensing
:
Phone: (901) 595-2342
Fax: (901) 595-3148
OTL Intellectual Properties Newsletters
More technologies
Antibodies for basic research
Biologics
Diagnostics
Drugs
Other technologies
Vaccines
Contact Us
View all Shared Resources